Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
Qiaozhu Su, Virender Kumar, Neetu Sud, et al.
Advanced Drug Delivery Reviews (2018) Vol. 129, pp. 54-63
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
Santosh Kumar, Qihua Duan, Rongxue Wu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113869-113869
Closed Access | Times Cited: 210
SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
Yunfeng Shen, Lidan Cheng, Minxuan Xu, et al.
Metabolism (2023) Vol. 146, pp. 155657-155657
Closed Access | Times Cited: 43
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
Jorge Torres, Ignacio Novo‐Veleiro, Laura Manzanedo, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 36, pp. 4104-4118
Open Access | Times Cited: 103
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
Virender Kumar, Xiaofei Xin, Jingyi Ma, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113888-113888
Open Access | Times Cited: 101
Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Haiou Li, Yunjiao Zhou, Haizhou Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 90
lncRNA GAS5 restrains CCl4-induced hepatic fibrosis by targeting miR-23a through the PTEN/PI3K/Akt signaling pathway
Zhiheng Dong, Sha Li, Xiaohui Wang, et al.
AJP Gastrointestinal and Liver Physiology (2019) Vol. 316, Iss. 4, pp. G539-G550
Closed Access | Times Cited: 80
Major roles of kupffer cells and macrophages in NAFLD development
Soo-Jeung Park, Josefina Garcia Diaz, Eugene Um, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 35
Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease
Siti Aishah Sulaiman, Nor I A Muhsin, Rahman Jamal
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 57
Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology
Yuanshe Huang, Xiaodong Wang, Yan Chen, et al.
Medicine (2022) Vol. 101, Iss. 43, pp. e31437-e31437
Open Access | Times Cited: 32
Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
Yudi Liao, Liya Wang, Fang Liu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 20
MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice
Ya‐Ling Yang, Hsing‐Chun Kuo, Feng‐Sheng Wang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1499-1499
Open Access | Times Cited: 50
The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications
E. Klieser, Christian Mayr, Tobias Kiesslich, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5266-5266
Open Access | Times Cited: 46
Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis
Shenghui Chen, Dan Chen, Hua Yang, et al.
BMC Gastroenterology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis
Shubham A. Salunkhe, Deepak Chitkara, Ram I. Mahato, et al.
Advanced Drug Delivery Reviews (2021) Vol. 173, pp. 394-415
Closed Access | Times Cited: 39
Druggability of lipid metabolism modulation against renal fibrosis
Yuanyuan Chen, Xiaoguang Chen, Sen Zhang
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 3, pp. 505-519
Open Access | Times Cited: 37
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154809-154809
Closed Access | Times Cited: 13
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights
Ιωάννα Αγγελετοπούλου, Efthymios P. Tsounis, Christos Triantos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4901-4901
Open Access | Times Cited: 4
Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway
Qingxian Cai, Fengjuan Chen, Fen Xu, et al.
Metabolism (2020) Vol. 104, pp. 154140-154140
Closed Access | Times Cited: 35
Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy
De Ji, Qiaohan Wang, Qi Zhao, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 32
LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3
Wei Huang, Feizhou Huang, Rui Zhang, et al.
Cell Cycle (2021) Vol. 20, Iss. 5-6, pp. 490-507
Open Access | Times Cited: 28
The relationship between non-alcoholic fatty liver disease and hypothyroidism
Xiaoxu Zeng, Bin Li, Yang Zou
Medicine (2021) Vol. 100, Iss. 17, pp. e25738-e25738
Open Access | Times Cited: 28
The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver
Daniela Gabbia, Sara Carpi, Samantha Sarcognato, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 28
Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2
Abdullah S. Shatoor, Suliman Al Humayed, Hussain Almohiy
Journal of Physiology and Biochemistry (2021) Vol. 78, Iss. 1, pp. 151-168
Closed Access | Times Cited: 27
NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways
Z. Zhang, Rachel Moon, James L. Thorne, et al.
Nutrition Research Reviews (2021) Vol. 36, Iss. 1, pp. 120-139
Open Access | Times Cited: 27
Delivery of Eicosapentaenoic acid-loaded cellulose nanocrystal alleviates liver fibrosis via modulating phospholipids and apoptotic regulators
Jihan Hussein, Dalia Medhat, Mona El Bana, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105796-105796
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top